Optimizing Outcomes in Patients With Inflammatory Bowel Diseases: The Critical Role of the GI Nurse

In this downloadable slideset, Karen A. Hanson, APRN, CN, and Joshua R. Korzenik, MD, review the critical role of the gastroenterology nurse in monitoring, evaluating, and communicating benefits and risks of treatment and applying strategies to improve adherence in patients with inflammatory bowel disease.
Format: Microsoft PowerPoint (.ppt)
File Size: 2.04 MB
Released: December 12, 2016


Produced in collaboration with
Supported by an educational grant from
Takeda Pharmaceuticals USA, LLC

Related Content

Expert commentary from Dr. Millie Long on developing “activated” patients with IBD in your practice, from Clinical Care Options (CCO)

Millie D. Long, MD, MPH Released: July 13, 2021

Downloadable slides covering best practices of shared-decision making and discussing cancer risk when discussing initiation of biologic therapy with patients who have IBD

Millie D. Long, MD, MPH Released: June 24, 2021

Interactive video from Dr. Millie Long and Clinical Care Options (CCO) on implementing shared decision-making in IBD management

Millie D. Long, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: June 23, 2021 Expired: June 22, 2022

Expert commentary from Dr. Bruce Sands on therapeutic drug monitoring in IBD, from Clinical Care Options (CCO)

Bruce E. Sands, MD, MS Released: June 3, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.